# Trial to Evaluate Tibolone in the Treatment of Osteoporosis (P06468)

> **NCT00519857** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 4534 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** Tibolone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00519857
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-07
- **Primary completion:** 2006-08
- **Final completion:** 2006-08
- **Target enrollment:** 4534 (ACTUAL)
- **Last updated:** 2022-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00519857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00519857, "Trial to Evaluate Tibolone in the Treatment of Osteoporosis (P06468)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00519857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*